Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Daniel, Peter Prof. Dr. (2) Hinz, Michael Dr. (2) Kammertöns, Thomas Dr. (3) Kirchner, Marieluise Dr. (2) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lusatis, Simone (1) Pombo, Ana Prof. Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Scheidereit, Claus Prof. Dr. (3) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (9) Uckert, Wolfgang Prof. Dr. (1) Willimsky, Gerald Dr. (1) Wollert-Wulf, Brigitte (2) Wyler, Emanuel Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (12) (-) Janz, Martin Dr. (7) (-) Mathas, Stephan Dr. (10) (-) Biologie maligner Lymphome (13) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (12) Tumorgenetik und zelluläre Stressantworten (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (4) 2000 (10) 2001 (6) (-) 2002 (11) 2003 (12) 2004 (11) 2005 (13) (-) 2006 (6) 2007 (9) 2008 (9) 2009 (6) 2010 (10) 2011 (9) (-) 2012 (8) 2013 (14) 2014 (6) 2015 (8) 2016 (7) 2017 (11) 2018 (5) 2019 (8) 2020 (6) 2021 (7) 2022 (13) 2023 (14) 2024 (4) 25 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Janz, Martin Dr.Mathas, Stephan Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie 200220062012 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou 01. August 2002 / J Mol Med Naive CD8+ but not CD4+ T cells induce maturation of dendritic cells T. Schueler T. Blankenstein 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken 01. April 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler 01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken 03. Juni 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein 15. Mai 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger 01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou
01. August 2002 / J Mol Med Naive CD8+ but not CD4+ T cells induce maturation of dendritic cells T. Schueler T. Blankenstein
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken
01. April 2002 / Trends Immunol Cross-priming versus cross-tolerance: are two signals enough? T. Blankenstein T. Schueler
01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
03. Juni 2002 / J Exp Med Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction Z. Qin H.J. Kim J. Hemme T. Blankenstein
15. Mai 2002 / Canc Res Increased tumorigenicity, but unchanged immunogenicity, of transporter for antigen presentation 1-deficient tumors Z. Qin C. Harders X. Cao C. Huber T. Blankenstein B. Seliger
01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer